ERBB2 and breast carcinoma: Predictive factors for BM with breast cancer have been identified, such as an overexpression of human epidermal growth factor receptor 2 (HER2), a lack of expression of hormone receptors, a patient age under 50 years, a triple negative subtype and the presence of lung metastases [6–10].